Visitors were particularly impressed by Tsingke's automation capabilities and flexible modular equipment designed to support high-purity, long-chain, and highly modified oligonucleotide synthesis. The ...

Oligo Factory’s new low-scale synthesis capability gives researchers the flexibility to order single oligos or small prototype batches, at volumes as low as 50 nmol with the same speed, service, and ...